This inventor holds 1 USPTO granted patent. Top assignee: The Hong Kong Polytechnic University. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Stanton Hon Lung Kok: Innovator in Anti-Tumor Agents
Introduction
Stanton Hon Lung Kok is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-tumor agents. His innovative work has the potential to impact cancer treatment positively.
Latest Patents
Stanton Hon Lung Kok holds a patent for "Water-soluble polymer-based cantharimides as potentially selective anti-tumor agents." This patent describes a cantharimide compound that may include a specific backbone structure. The compound's components can be independently selected from various groups, including hydrogen, C-alkyl, and bioactive polymers, which enhances its potential effectiveness in targeting tumors.
Career Highlights
Stanton is affiliated with The Hong Kong Polytechnic University, where he engages in research and development in the field of medicinal chemistry. His work is characterized by a commitment to advancing scientific knowledge and improving therapeutic options for cancer patients.
Collaborations
Stanton has collaborated with esteemed colleagues such as Johnny Cheuk-on Tang and Albert Sun-chi Chan. These partnerships have fostered a collaborative environment that enhances the research output and innovation in their respective fields.
Conclusion
Stanton Hon Lung Kok is a prominent inventor whose work in anti-tumor agents showcases his dedication to advancing medical science. His contributions are vital in the ongoing fight against cancer, and his innovative spirit continues to inspire future research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile